BioFire® FilmArray® Panels
Fast and comprehensive syndromic PCR panels take out the guesswork, giving laboratories and healthcare providers a rapid way of identifying pathogens associated with infectious disease. Designed with the syndromic approach in mind, each panel can detect a broad grouping of probable pathogenic causes in a single, accurate, rapid test.
Syndromic testing for upper and lower respiratory tract infections
The BioFire® syndromic respiratory solution allow for rapid testing for the most common viruses, bacteria, and antimicrobial resistance genes associated with infections in the upper- and lower respiratory tract. Whether you’re trying to select appropriate therapy for a pneumonia patient or determine exactly which respiratory pathogen is making a young child sick, the BioFire® can quickly aid in providing answers to the cause of the condition of the patient.
 |
 |
 |
| The BioFire® Respiratory 2.1 Plus (RP2.1plus) Panel | The BioFire® Pneumonia Plus (PNplus) Panel | BioFire® Syndromic Trends |
The BioFire® Respiratory 2.1 Plus (RP2.1plus) Panel
One Test. 23 Targets. One Hour.
The BioFire® RP2.1plus Panel uses a syndromic approach to accurately detect and identify the pathogens most commonly associated with respiratory infections.
Fast and comprehensive, the RP2.1plus Panel offers a run time of 45 minutes, enabling high efficiency and throughput on the BioFire® FilmArray® 2.0 and the BioFire® FilmArray® Torch Systems. Rapid respiratory PCR test results may enable better-informed diagnosis and treatment of patients.
BioFire® Respiratory 2.1 Plus (RP2.1plus) Panel
Benefits of the BIOFIRE® Respiratory 2.1 Plus Panel
Fast. Easy. Comprehensive.
 |
 |
 |
Faster Time to Results |
Targeted Treatment Decisions |
Reduce Length of Stay |
| The BioFire® Respiratory 2.1 Plus (RP2.1 plus) Panel can dramatically reduce time to diagnosis compared to traditional testing methods.1,2,3,4,5,6,7 | Targeted testing runs the risk of missing the true causative agent. Fast, accurate results give you the confidence to reduce antibiotic use 8,9,10,11,12,13 or use neuraminidase inhibitors more appropriately.9,11,12 | Improved care management regarding admissions, isolations, cohorting, and discharges with the BioFire® Respiratory 2.1 plus (RP2.1plus) Panel |
SYNDROMIC TESTING IN CHILDREN
Respiratory infections are common in children and the symptoms are often unspecific, making the diagnosis a challenge. The syndromic approach can aid in rapid pathogen identification in paediatric patients, where the variety of possible causative pathogens can be high, even during the SARS-COV-2 pandemic.28
Download the pediatrician brochure
The BioFire® Pneumonia Plus (PNplus) Panel
One Test. 34 Targets. One Hour.
The BioFire PN plus panel is the only FDA-cleared and CE-marked sample-to-answer capable of identifying 34 clinically relevant targets from sputum (including endotracheal aspirate) and bronchoalveolar lavage (including mini-BAL) samples. For 15 of the bacteria, the PN plus Panel provides semi-quantitative results, which may help determine whether an organism is a colonizer or a pathogen.
BioFire Pneumonia Plus (PNplus) Panel
Benefits of the BIOFIRE® Pneumonia Plus Panel
Fast. Easy. Comprehensive.
|
|
|
Faster time to results |
Impact on treatment decisions |
Impact on patient health outcomes |
|
The BioFire® Pneumonia Plus Panel can dramatically reduce time to diagnosis compared to traditional testing methods. Time to result in about one hour, leading to 39h reduction for pathogen identification14-18 and 61h for AST14,15,16,18. |
Semi-quantitative results to help distinguish pathogens of interest from normal flora
|
The hospital length of stay is decreased dramatically.
|
Webinars & Testimonials
Recording - Watch this video:
Dr. Henry Paridaens
Hopital La Citadelle
Webinar: Navigating the Respiratory Season, The Power of Syndromic Testing
What is BioFire® Syndromic Trends?
BioFire Syndromic Trends (Trend) is an IT solution offered by bioMérieux, that provides instant, visual insights into local and regional pathogen detection trends on demand. Users can view pathogen trends for their lab as well as regional and national pathogen trends, all of which are created from de-identified data that has been aggregated with BioFire® test data from other participating sites. Trend delivers automatic weekly email reports and allows users to explore their data using a Trend’s online dashboard, which enables users to further explore their data by location, laboratory, or even chart type. Trends is available for RP2.1plus & BCID2 panels.
BioFire® Syndromic Trends Features
- Downloadable custom reports
- De-identified data to protect patient privacy
- Weekly notifications for local and regional activity
- Near real-time data collection and historical data access
- Unlimited licenses to clinical website for data collection
Diverse Resources To Download
DISCOVER ALL SIX SYNDROMIC PANELS OF BIOFIRE®
|
BioFire® Meningitis/Encephalitis Panel 1 Test. 14 Targets. ~1 Hour. |
BioFire® Joint Infection Panel 1 Test. 39 Targets. ~ 1 Hour. |
BioFire® Respiratory 2.1 Plus Panel 1 Test. 23 Targets. ~45minutes. |
|
BioFire® Blood Culture Identification 2 Panel 1 Test. 43 Targets. ~1 Hour. |
BioFire® Gastrointestinal Panel 1 Test. 22 Targets. ~1 Hour. |
BioFire® Pneumonia Plus Panel 1 Test. 34 Targets. ~1 Hour. |
Access Consolidated Review of the Benefits of AMS Practices